Small Molecules Facilitate the Reprogramming of Mouse Fibroblasts into Pancreatic Lineages
Cell Stem Cell, Volume 14, Issue 2, 228-236, 6 February 2014
Copyright © 2014 Elsevier Inc. All rights reserved.
10.1016/j.stem.2014.01.006
Authors
- Highlights
- Fibroblasts can be directly reprogrammed into definitive endoderm-like cells (DELCs)
- Small molecules can then guide DELCs into pancreatic progenitor-like cells (PPLCs)
- PPLCs give rise to all three pancreatic lineages in vivo
- Functional β-like cells derived from transplanted PPLCs ameliorate hyperglycemia
Summary
Pancreatic β cells are of great interest for the treatment of type 1 diabetes. A number of strategies already exist for the generation of β cells, but a general approach for reprogramming nonendodermal cells into β cells could provide an attractive alternative in a variety of contexts. Here, we describe a stepwise method in which pluripotency reprogramming factors were transiently expressed in fibroblasts in conjunction with a unique combination of soluble molecules to generate definitive endoderm-like cells that did not pass through a pluripotent state. These endoderm-like cells were then directed toward pancreatic lineages using further combinations of small molecules in vitro. The resulting pancreatic progenitor-like cells could mature into cells of all three pancreatic lineages in vivo, including functional, insulin-secreting β-like cells that help to ameliorate hyperglycemia. Our findings may therefore provide a useful approach for generating large numbers of functional β cells for disease modeling and, ultimately, cell-based therapy.
No hay comentarios:
Publicar un comentario